The Recall Desk

Category

Drug recalls

FDA recalls of prescription and over-the-counter drugs.

About drug recalls

FDA drug recalls cover prescription medicines, over-the-counter products, biologic and gene therapies, and active pharmaceutical ingredients (the raw drug substances that manufacturers compound into finished products). Recall classifications follow the same Class I / II / III system as food, and most published recalls are Class II — the product is unlikely to cause permanent harm but doesn't meet specification.

The most common reasons for a drug recall are out-of-specification potency or dissolution (the active ingredient is present in too high or too low a dose), microbial contamination, particulate matter in injectables, mix-ups during packaging where bottles end up with the wrong tablets, and nitrosamine impurities in certain drug classes. Many drug recalls are at the lot level — the manufacturer's whole product line is still safe to use, but specific production lots are pulled.

If a recall affects your medication: don't stop taking it on your own. Call your prescriber or pharmacist before doing anything. Stopping a prescribed drug abruptly can be more dangerous than the issue prompting the recall. Most drug-recall remedies route through the dispensing pharmacy, who'll either swap your supply for an unaffected lot or coordinate a refund with the manufacturer.

476–500 of 5132

  • HighFDA (Drugs)·D-0235-2026·2025-12-24

    [pending] BACLOFEN (BACLOFEN)

    Pending LLM rewrite. Source: FDA_DRUG D-0235-2026.

    Product
    BACLOFEN — BACLOFEN (BACLOFEN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0230-2026·2025-12-24

    [pending] POLOCAINE (MEPIVACAINE HYDROCHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0230-2026.

    Product
    POLOCAINE — POLOCAINE (MEPIVACAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0222-2026·2025-12-17

    [pending] NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0222-2026.

    Product
    NEBIVOLOL — NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0224-2026·2025-12-17

    [pending] CINACALCET (CINACALCET)

    Pending LLM rewrite. Source: FDA_DRUG D-0224-2026.

    Product
    CINACALCET — CINACALCET (CINACALCET)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0225-2026·2025-12-17

    [pending] CINACALCET (CINACALCET)

    Pending LLM rewrite. Source: FDA_DRUG D-0225-2026.

    Product
    CINACALCET — CINACALCET (CINACALCET)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0226-2026·2025-12-17

    [pending] CINACALCET (CINACALCET)

    Pending LLM rewrite. Source: FDA_DRUG D-0226-2026.

    Product
    CINACALCET — CINACALCET (CINACALCET)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0220-2026·2025-12-17

    [pending] GANIRELIX ACETATE (GANIRELIX ACETATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0220-2026.

    Product
    GANIRELIX ACETATE — GANIRELIX ACETATE (GANIRELIX ACETATE)
    Category
    Drug
    Distribution
    4 states
  • HighFDA (Drugs)·D-0223-2026·2025-12-17

    [pending] MORPHINE SULFATE (MORPHINE SULFATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0223-2026.

    Product
    MORPHINE SULFATE — MORPHINE SULFATE (MORPHINE SULFATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0221-2026·2025-12-17

    [pending] Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, 0.5m

    Pending LLM rewrite. Source: FDA_DRUG D-0221-2026.

    Product
    Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, 0.5mL Single-Use Syringe, For Topical Ophthalmic Use Only. Not for IV Use. Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67226. NDC: 71266-8240-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0217-2026·2025-12-17

    [pending] LANTHANUM CARBONATE (LANTHANUM CARBONATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0217-2026.

    Product
    LANTHANUM CARBONATE — LANTHANUM CARBONATE (LANTHANUM CARBONATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0218-2026·2025-12-17

    [pending] LANTHANUM CARBONATE (LANTHANUM CARBONATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0218-2026.

    Product
    LANTHANUM CARBONATE — LANTHANUM CARBONATE (LANTHANUM CARBONATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0219-2026·2025-12-17

    [pending] VARENICLINE TARTRATE (VARENICLINE TARTRATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0219-2026.

    Product
    VARENICLINE TARTRATE — VARENICLINE TARTRATE (VARENICLINE TARTRATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0205-2026·2025-12-10

    [pending] ZINC OXIDE (ZINC OXIDE OINTMENT)

    Pending LLM rewrite. Source: FDA_DRUG D-0205-2026.

    Product
    ZINC OXIDE — ZINC OXIDE (ZINC OXIDE OINTMENT)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0209-2026·2025-12-10

    [pending] NIVAGEN ZINC OXIDE (ZINC OXIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0209-2026.

    Product
    NIVAGEN ZINC OXIDE — NIVAGEN ZINC OXIDE (ZINC OXIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0216-2026·2025-12-10

    [pending] DULOXETINE (DULOXETINE HYDROCHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0216-2026.

    Product
    DULOXETINE — DULOXETINE (DULOXETINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0207-2026·2025-12-10

    [pending] DYNASHIELD (ZINC OXIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0207-2026.

    Product
    DYNASHIELD — DYNASHIELD (ZINC OXIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0212-2026·2025-12-10

    [pending] ZINC OXIDE 20% (ZINC OXIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0212-2026.

    Product
    ZINC OXIDE 20% — ZINC OXIDE 20% (ZINC OXIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0211-2026·2025-12-10

    [pending] CLOTRIMAZOLE (CLOTRIMAZOLE)

    Pending LLM rewrite. Source: FDA_DRUG D-0211-2026.

    Product
    CLOTRIMAZOLE — CLOTRIMAZOLE (CLOTRIMAZOLE)
    Category
    Drug
    Distribution
    Distributed nationwide

Looking for a different category? Browse all recalls.